(Q38410039)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

main subject

phase III clinical trial

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Stephen Tyring

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alice Gottlieb

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ken Gordon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Craig Leonardi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Andrea Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Deepa Lalla

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Michael Woolley

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Angelika Jahreis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ralph Zitnik

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

David Cella

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ranga Krishnan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

367

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

29-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

9504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction

15 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Quality of life in patients with psoriasis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Sleep, the hypothalamic-pituitary-adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Etanercept as monotherapy in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Fatigue in cancer patients compared with fatigue in the general United States population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Assessment of depression in subjects with psoriasis vulgaris and lichen planus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Is the efficacy of topical corticosteroid therapy for psoriasis vulgaris enhanced by concurrent moclobemide therapy? A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

The burden of psoriasis is not determined by disease severity only.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

The Salford Psoriasis Index: an holistic measure of psoriasis severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967763-X

7 January 2021

10.1016/S0140-6736(05)67763-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16399150%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference